AJP - Renal Physiology, Vol 271, Issue 2 374-F381, Copyright © 1996 by American Physiological Society

ARTICLES

Effects of intravenous adenosine on renal function in healthy human subjects

V. S. Balakrishnan, G. A. Coles and J. D. Williams
Institute of Nephrology, University of Wales College of Medicine, Cardiff Royal Infirmary, United Kingdom.

The vasoactive nucleoside adenosine has an important regulatory influence on most aspects of renal function in experimental animals. In this study, we evaluated the effects of intravenous adenosine on systemic and renal hemodynamics, tubular function, and plasma renin concentration in 10 healthy male subjects. Each of the subjects received two intravenous infusions of adenosine (70 micrograms.kg-1.min-1) and saline on three separate study days. There was no significant change in systemic blood pressure in response to adenosine, although there was a significant rise in heart rate postcommencement of adenosine (61.5 +/- 2.9 to 78.0 +/- 7.9 beats/min, 1 h postcommencement of adenosine on day 1, P < 0.01 vs. saline). There was a significant decline in 51Cr-EDTA clearance (glomerular filtration rate) (118.5 +/- 13.2 to 88.0 +/- 8.3 ml/min, P < 0.05 vs. saline) and filtration fraction (19.4 +/- 1.01 to 16.0 +/- 1.03%, P < 0.01 vs. saline) 1 h postcommencement of adenosine, although there was no significant change in 125I-hippuran clearance (effective renal plasma flow). Urine flow rate and osmolar and free water clearance decreased significantly in response to adenosine (particularly on study day 1). There was, in addition, a significant reduction in absolute and fractional excretion rates of sodium, lithium, phosphate, uric acid, chloride, and urea in response to adenosine. There was a rise in plasma renin concentration in response to adenosine, reaching levels of statistical significance on study day 1 (15.0 +/- 2.02 to 22.2 +/- 2.00 microU/ml, 1 h postcommencement of adenosine; P < 0.05 vs. saline). These data are consistent with observations in experimental animals and complement the results of previous studies in man using a selective adenosine A1-receptor antagonist, thereby confirming that adenosine has a significant regulatory influence on human renal function.

This article has been cited by other articles:

				A. Kulick, C. Panico, P. Gill, and W. J. Welch Low salt intake increases adenosine type 1 receptor expression and function in the rat proximal tubule Am J Physiol Renal Physiol, July 1, 2008; 295(1): F37 - F41. [Abstract] [Full Text] [PDF]

				H. Castrop Modulation of adenosine receptor expression in the proximal tubule: a novel adaptive mechanism to regulate renal salt and water metabolism Am J Physiol Renal Physiol, July 1, 2008; 295(1): F35 - F36. [Full Text] [PDF]

				V. Vallon, B. Muhlbauer, and H. Osswald Adenosine and kidney function. Physiol Rev, July 1, 2006; 86(3): 901 - 940. [Abstract] [Full Text] [PDF]

				M. Gellai, G. F. Schreiner, R. R. Ruffolo Jr., T. Fletcher, R. DeWolf, and D. P. Brooks CVT-124, a Novel Adenosine A1 Receptor Antagonist with Unique Diuretic Activity J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1191 - 1196. [Abstract] [Full Text]

				R. Brown, A. Ollerstam, B. Johansson, O. Skott, S. Gebre-Medhin, B. Fredholm, and A. E. G. Persson Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1362 - R1367. [Abstract] [Full Text] [PDF]